Kyle Gilmour

512 total citations
7 papers, 375 citations indexed

About

Kyle Gilmour is a scholar working on Oncology, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Kyle Gilmour has authored 7 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Obstetrics and Gynecology. Recurrent topics in Kyle Gilmour's work include Cancer Risks and Factors (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Kyle Gilmour is often cited by papers focused on Cancer Risks and Factors (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Kyle Gilmour collaborates with scholars based in United Kingdom and Canada. Kyle Gilmour's co-authors include Henry C Kitchener, Hilary Buckley, Anthony M. Heagerty, Nicola Cherry, Max Elstein, Clifford R. Kay, Philip C Hannaford, Roseanne McNamee, Emma J. Crosbie and Vanitha N. Sivalingam and has published in prestigious journals such as The Lancet, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Kyle Gilmour

7 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kyle Gilmour United Kingdom	5	210	186	101	96	50	7	375
J Jassem Poland	8	118 0.6×	140 0.8×	36 0.4×	155 1.6×	35 0.7×	23	318
Merja B. Marttunen Finland	8	77 0.4×	191 1.0×	50 0.5×	124 1.3×	80 1.6×	9	389
J. Robinson United Kingdom	10	143 0.7×	146 0.8×	36 0.4×	57 0.6×	37 0.7×	12	325
C. A. Haiman United States	3	76 0.4×	162 0.9×	197 2.0×	105 1.1×	13 0.3×	3	388
Izabella Czajka-Oraniec Poland	8	104 0.5×	88 0.5×	46 0.5×	130 1.4×	11 0.2×	17	352
Tereza Hálková Czechia	10	76 0.4×	42 0.2×	91 0.9×	96 1.0×	62 1.2×	22	355
Usha Sriram India	8	107 0.5×	166 0.9×	150 1.5×	170 1.8×	6 0.1×	13	435
Messan G. Amewou-Atisso United States	6	90 0.4×	182 1.0×	61 0.6×	115 1.2×	7 0.1×	8	312
Silvia Pecchio Italy	8	53 0.3×	67 0.4×	58 0.6×	143 1.5×	11 0.2×	13	306
Stalo Karageorgi United States	7	32 0.2×	66 0.4×	45 0.4×	43 0.4×	80 1.6×	7	296

Countries citing papers authored by Kyle Gilmour

Since Specialization

Citations

This map shows the geographic impact of Kyle Gilmour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Gilmour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Gilmour more than expected).

Fields of papers citing papers by Kyle Gilmour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Gilmour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Gilmour. The network helps show where Kyle Gilmour may publish in the future.

Co-authorship network of co-authors of Kyle Gilmour

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Gilmour. A scholar is included among the top collaborators of Kyle Gilmour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Gilmour. Kyle Gilmour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Kitson, Sarah, Vanitha N. Sivalingam, Jennifer L. Allen, et al.. (2018). PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial. Clinical Cancer Research. 25(8). 2424–2432. 44 indexed citations

2.

Kitson, Sarah, Vanitha N. Sivalingam, Jennifer L. Allen, et al.. (2018). Pre-Surgical Metformin in Uterine Malignancy (Premium): A Multi-Centre, Randomised Double-Blind, Placebo-Controlled Phase 3 Trial. SSRN Electronic Journal. 2 indexed citations

3.

Sivalingam, Vanitha N., Sarah Kitson, Rhona J. McVey, et al.. (2016). Measuring the biological effect of presurgical metformin treatment in endometrial cancer. British Journal of Cancer. 114(3). 281–289. 72 indexed citations

4.

Sivalingam, Vanitha N., Rhona J. McVey, Kyle Gilmour, et al.. (2015). A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancer. The Lancet. 385. S90–S90. 19 indexed citations

5.

Sivalingam, Vanitha N., Rhona J. McVey, Sarah Kitson, et al.. (2015). Pre-surgical window study of metformin in obesity-driven endometrial cancer. Gynecologic Oncology. 137. 18–18. 3 indexed citations

6.

Gilmour, Kyle, et al.. (2007). Increased serum carcinomic antigen 19-9(CA 19-9) in a dermoid cyst. Journal of Obstetrics and Gynaecology. 27(1). 96–97. 9 indexed citations

7.

Cherry, Nicola, Kyle Gilmour, Philip C Hannaford, et al.. (2002). Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. The Lancet. 360(9350). 2001–2008. 226 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact